This process is triggered by factors such as transforming growth factor beta (TGF-β) and fibroblast growth factor 2 (FGF2) deficiency, chronic inflammation, and viral infection (e.g., KSHV in Kaposi’s sarcoma). This evidence concerns the gene FGF2 and viral infectious disease.